← Back to Ingredients

Magnesium Glycinate

A highly bioavailable chelated form of magnesium bonded to the amino acid glycine, studied for sleep quality, muscle relaxation, and GABA receptor modulation with minimal gastrointestinal side effects.

Sleep QualityMuscle RelaxationGABA Receptor ModulationSuperior AbsorptionStress Recovery

Magnesium Glycinate

Magnesium is the fourth most abundant mineral in the human body and a cofactor in over 300 enzymatic reactions governing energy production, protein synthesis, muscle and nerve function, blood glucose control, and neurotransmitter regulation. Despite its critical importance, subclinical magnesium deficiency is widespread, affecting an estimated 50-80% of adults in Western populations due to soil depletion, processed food consumption, and chronic stress (which accelerates magnesium excretion).

Magnesium glycinate is a chelated form in which elemental magnesium is bonded to two molecules of the amino acid glycine. This chelation dramatically improves intestinal absorption compared to inorganic forms like magnesium oxide (which has only 4% bioavailability) and virtually eliminates the laxative effect that makes high-dose magnesium citrate or oxide poorly tolerated.

How It Works

Magnesium's relevance to sleep and relaxation stems primarily from its role as a natural GABA receptor agonist. It binds to GABA-A receptors and potentiates their inhibitory signaling, promoting neural quieting and reducing the excitatory neural firing that keeps the mind active at night. This mechanism is similar to (though gentler than) the action of benzodiazepines, without the sedation, dependence, or cognitive impairment.

Magnesium also blocks NMDA receptors, which are excitatory glutamate receptors. By reducing glutamate-driven excitation while enhancing GABA-driven inhibition, magnesium shifts the brain's neurochemical balance toward relaxation. This dual action makes it particularly valuable for individuals whose sleep difficulties are driven by an overactive, racing mind.

At the muscular level, magnesium regulates calcium channel activity. Calcium triggers muscle contraction; magnesium enables relaxation by displacing calcium from troponin binding sites. Insufficient magnesium leads to sustained muscle tension, cramps, and restless legs, all common disruptors of sleep quality.

The glycine component provides additional benefits. Glycine is itself an inhibitory neurotransmitter that has been shown to lower core body temperature (a prerequisite for sleep onset) and improve subjective sleep quality. In magnesium glycinate, both the mineral and the amino acid carrier contribute to the calming effect.

Clinical Evidence

Abbasi et al. (2012) conducted a double-blind, placebo-controlled trial in elderly participants with insomnia and found that 500mg of magnesium (as oxide, but representative of magnesium supplementation broadly) significantly improved sleep time, sleep efficiency, melatonin levels, and serum cortisol compared to placebo over 8 weeks.

Held et al. (2002) demonstrated using polysomnography that magnesium supplementation increased slow-wave (deep) sleep duration and reduced nighttime cortisol levels in healthy older adults, indicating effects on both sleep architecture and HPA axis activity.

A 2017 systematic review by Cao et al. concluded that magnesium supplementation appears to improve subjective measures of insomnia, including sleep onset latency and sleep quality, particularly in individuals with low baseline magnesium status.

For the glycine component, Inagawa et al. (2006) showed that 3g of glycine before bedtime significantly improved subjective sleep quality and reduced daytime sleepiness in individuals with difficulty sleeping. Bannai et al. (2012) confirmed these findings and demonstrated that glycine improved both subjective and objective sleep measures without affecting sleep architecture negatively.

Regarding the glycinate form specifically, Schuette et al. (1994) demonstrated that chelated magnesium forms (including glycinate) showed significantly higher fractional absorption compared to magnesium oxide in direct bioavailability comparisons.

Dosing and Safety

The recommended supplemental dose of elemental magnesium is 200-400mg daily for adults, with 300-400mg being the typical dose studied for sleep support. Magnesium glycinate is best taken 30-60 minutes before bedtime for sleep applications. It can be split into two doses (morning and evening) for general relaxation and muscle recovery.

Magnesium glycinate is exceptionally well tolerated. The chelated form produces significantly fewer gastrointestinal side effects than magnesium oxide, citrate, or sulfate. Even at higher doses, loose stools are uncommon with the glycinate form, making it suitable for individuals with sensitive digestion.

Contraindications include severe renal impairment (the kidneys are responsible for magnesium excretion, and impaired clearance can lead to hypermagnesemia), myasthenia gravis, and concurrent use of aminoglycoside antibiotics. Magnesium can reduce the absorption of certain medications including bisphosphonates, tetracycline antibiotics, and levothyroxine. Separate dosing by at least 2 hours.

The tolerable upper intake level established by the Institute of Medicine is 350mg of supplemental elemental magnesium daily, though this refers specifically to pharmacological supplementation and does not include dietary magnesium.

Ankhora Products Containing Magnesium Glycinate

Lunar Rest features magnesium glycinate as a core ingredient in a sleep-focused formulation designed to improve sleep onset, depth, and morning freshness.

Evening Wind-Down includes magnesium glycinate alongside L-Theanine and other calming compounds to support the transition from daily activity to restful relaxation.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.